Celldex Therapeutics Stock Price Falls 1.9%
2026-09-22 21:37:02
According to CoinMeta, as reported by Reuters, the stock price of Celldex Therapeutics fell by 1.9% due to a poor market reaction following the release of late-stage trial data for its skin disease medication.
Source:Internet
This content is for market information only and does not constitute investment advice.
Follow CoinMeta official accounts to stay updated

Hot Articles
Refresh

What is Bybit Exchange? Is Bybit Safe with EU Dual Licenses?
09-21 18:42

Bitcoin 5-Year Outlook: $75.5K Miner Cost, Crash or Floor?
09-20 19:23

Legit Bitcoin Trading Apps 2026: Top 4 Safe & Regulated Picks
09-18 18:52

Zcash Jumps 23% After Fed Hike, Beats Bitcoin: How Far Can It Go?
09-17 18:03

Which Crypto Wallet Is Best? 2026 Ranking & Review
09-16 18:34



